AR102555A1 - Inmunoterapia t específica de múltiples péptidos terapéuticos para el tratamiento de metástasis cerebral - Google Patents
Inmunoterapia t específica de múltiples péptidos terapéuticos para el tratamiento de metástasis cerebralInfo
- Publication number
- AR102555A1 AR102555A1 ARP150103601A ARP150103601A AR102555A1 AR 102555 A1 AR102555 A1 AR 102555A1 AR P150103601 A ARP150103601 A AR P150103601A AR P150103601 A ARP150103601 A AR P150103601A AR 102555 A1 AR102555 A1 AR 102555A1
- Authority
- AR
- Argentina
- Prior art keywords
- seq
- treatment
- therapeutic peptides
- peptides
- brain
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 238000009169 immunotherapy Methods 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 4
- 210000004556 brain Anatomy 0.000 title abstract 2
- BVAUMRCGVHUWOZ-ZETCQYMHSA-N (2s)-2-(cyclohexylazaniumyl)propanoate Chemical compound OC(=O)[C@H](C)NC1CCCCC1 BVAUMRCGVHUWOZ-ZETCQYMHSA-N 0.000 abstract 1
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 abstract 1
- 208000003174 Brain Neoplasms Diseases 0.000 abstract 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010059282 Metastases to central nervous system Diseases 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 229940023041 peptide vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Abstract
Composición OSE-2101 de vacuna de péptidos para el tratamiento de metástasis cerebral en pacientes HLA-A2 positivos. Reivindicación 1: Una inmunoterapia T específica de péptidos terapéuticos para uso en el tratamiento de la metástasis cerebral de un paciente HLA-A2 (antígeno leucocitario humano A2) positivo, donde la inmunoterapia T específica de péptidos terapéuticos comprende los siguientes péptidos RLLQETELV (SEQ ID Nº 1), YLQLVFGIEV (SEQ ID Nº 2), LLTFWNPPV (SEQ ID Nº 3), KVFGSLAFV (SEQ ID Nº 4), KLBPVQLWV (SEQ ID Nº 5, con B indicando un ácido a-aminoisobutírico), SMPPPGTRV (SEQ ID Nº 6), IMIGHLVGV (SEQ ID Nº 7), KVAEIVHFL (SEQ ID Nº 8), YLSGADLNL (SEQ ID Nº 9), aKXVAAWTLKAAa (SEQ ID Nº 10, con X y a indicando respectivamente ciclohexilalanina y d-alanina). Reivindicación 6: La inmunoterapia T específica de péptidos terapéuticos para uso de acuerdo con una cualquiera de las reivindicaciones 1 a 5, donde los péptidos se emulsionan en adyuvante de Freund incompleto o similar, preferentemente Montanide ISA-51.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2014/073975 WO2016070928A1 (en) | 2014-11-06 | 2014-11-06 | Therapeutic multi-peptides t specific immune therapy for treatment of brain metastasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR102555A1 true AR102555A1 (es) | 2017-03-08 |
Family
ID=51871025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150103601A AR102555A1 (es) | 2014-11-06 | 2015-11-05 | Inmunoterapia t específica de múltiples péptidos terapéuticos para el tratamiento de metástasis cerebral |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10434157B2 (es) |
| EP (1) | EP3215184B1 (es) |
| JP (1) | JP6474893B2 (es) |
| KR (1) | KR102043725B1 (es) |
| CN (1) | CN107073087B (es) |
| AR (1) | AR102555A1 (es) |
| AU (1) | AU2014410466B2 (es) |
| BR (1) | BR112017009358A2 (es) |
| CA (1) | CA2963184C (es) |
| EA (1) | EA037271B1 (es) |
| ES (1) | ES2874006T3 (es) |
| IL (1) | IL250576B (es) |
| MX (1) | MX2017005807A (es) |
| NZ (1) | NZ729514A (es) |
| TW (1) | TWI703982B (es) |
| WO (1) | WO2016070928A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2990299C (en) * | 2015-06-29 | 2023-10-10 | Ose Immunotherapeutics | Method for inducing early t memory response with short peptides anti-tumor vaccine |
| SI3573600T1 (sl) * | 2017-01-25 | 2022-07-29 | Ose Immunotherapeutics | Postopek za proizvodnjo obstojne emulzije za dostavo peptida |
| KR102624844B1 (ko) * | 2017-11-27 | 2024-01-12 | 오제 이뮈노테라프틱스 | 암의 향상된 치료 |
| CN109988748A (zh) * | 2017-12-29 | 2019-07-09 | 深圳华大生命科学研究院 | 一种从til筛选肿瘤特异性t细胞的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080274129A1 (en) * | 2003-04-18 | 2008-11-06 | Fikes John D | Hla-A2 Tumor Associated Antigen Peptides and Compositions |
| PT2360258E (pt) * | 2005-02-18 | 2015-01-13 | Angiochem Inc | Moléculas para transportar um composto através da barreira hematoencefálica |
| PL2172211T3 (pl) * | 2008-10-01 | 2015-05-29 | Immatics Biotechnologies Gmbh | Kompozycja związanych z guzem peptydów i związana z tym szczepionka przeciwrakowa do leczenia glejaka (GBM) i innych rodzajów raka |
| CN103145803B (zh) * | 2012-12-13 | 2014-03-12 | 东南大学 | 一种与乳腺癌脑转移细胞特异性结合的多肽 |
-
2014
- 2014-11-06 AU AU2014410466A patent/AU2014410466B2/en active Active
- 2014-11-06 MX MX2017005807A patent/MX2017005807A/es unknown
- 2014-11-06 US US15/524,278 patent/US10434157B2/en active Active
- 2014-11-06 WO PCT/EP2014/073975 patent/WO2016070928A1/en active Application Filing
- 2014-11-06 ES ES14796049T patent/ES2874006T3/es active Active
- 2014-11-06 JP JP2017518779A patent/JP6474893B2/ja active Active
- 2014-11-06 NZ NZ729514A patent/NZ729514A/en unknown
- 2014-11-06 EP EP14796049.6A patent/EP3215184B1/en active Active
- 2014-11-06 KR KR1020177015327A patent/KR102043725B1/ko active IP Right Grant
- 2014-11-06 EA EA201790990A patent/EA037271B1/ru unknown
- 2014-11-06 CA CA2963184A patent/CA2963184C/en active Active
- 2014-11-06 BR BR112017009358A patent/BR112017009358A2/pt not_active Application Discontinuation
- 2014-11-06 CN CN201480082351.XA patent/CN107073087B/zh active Active
-
2015
- 2015-10-27 TW TW104135282A patent/TWI703982B/zh active
- 2015-11-05 AR ARP150103601A patent/AR102555A1/es unknown
-
2017
- 2017-02-13 IL IL250576A patent/IL250576B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN107073087B (zh) | 2020-09-08 |
| AU2014410466B2 (en) | 2019-09-12 |
| KR102043725B1 (ko) | 2019-11-13 |
| CA2963184A1 (en) | 2016-05-12 |
| CA2963184C (en) | 2020-11-24 |
| US10434157B2 (en) | 2019-10-08 |
| IL250576B (en) | 2019-09-26 |
| US20170319672A1 (en) | 2017-11-09 |
| EP3215184B1 (en) | 2021-03-03 |
| KR20170098811A (ko) | 2017-08-30 |
| JP2017533898A (ja) | 2017-11-16 |
| BR112017009358A2 (pt) | 2017-12-19 |
| WO2016070928A1 (en) | 2016-05-12 |
| MX2017005807A (es) | 2017-08-02 |
| IL250576A0 (en) | 2017-03-30 |
| EA037271B1 (ru) | 2021-03-02 |
| TW201625287A (zh) | 2016-07-16 |
| EP3215184A1 (en) | 2017-09-13 |
| AU2014410466A1 (en) | 2017-03-30 |
| ES2874006T3 (es) | 2021-11-04 |
| NZ729514A (en) | 2019-12-20 |
| EA201790990A1 (ru) | 2017-09-29 |
| CN107073087A (zh) | 2017-08-18 |
| JP6474893B2 (ja) | 2019-02-27 |
| TWI703982B (zh) | 2020-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123100T1 (el) | Μεθοδος για την παρασκευη amg 416 | |
| CY1120862T1 (el) | Παραγοντες επαγωγης αποπτωσης για τη θεραπευτικη αγωγη καρκινου και ανοσων και αυτοανοσων ασθενειων | |
| BR112017017293A2 (pt) | método para predizer modificações de aminoácidos, para selecionar e/ou classificar modificações de aminoácidos e para fornecer uma vacina e vacina | |
| DOP2017000271A (es) | Métodos de acondicionamiento de pacientes para tratamiento con linfocitos t | |
| MX2017014532A (es) | Vacunas para el tratamiento y prevencion del cancer. | |
| GEP20237528B (en) | Antibodies against signal-regulatory protein alpha and methods of use | |
| DOP2017000272A (es) | Métodos de diagnóstico para tratamiento con linfocitos t | |
| WO2014113490A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| CL2019002534A1 (es) | Plataforma de identificación de peptidos inmunogénicos personalizados. | |
| CR20160145A (es) | Proteínas de unión al antígeno gitr | |
| SA518390954B1 (ar) | لقاحات علاجية لفيروس الورم الحليمي البشري 18 | |
| AR102555A1 (es) | Inmunoterapia t específica de múltiples péptidos terapéuticos para el tratamiento de metástasis cerebral | |
| CY1120772T1 (el) | ΜΕΤΑΛΛΑΓΜΕΝΑ ΘΡΑΥΣΜΑΤΑ OspA ΚΑΙ ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ ΣΧΕΤΙΚΕΣ ΜΕ ΑΥΤΑ | |
| DOP2013000029A (es) | Anticuerpos peptidicos beta amiloide anti-n3pglu y usos de los mismos | |
| DK2280721T3 (da) | Indoleamin-2, 3-dioxygenasebaseret immunterapi | |
| BR112016016737A2 (pt) | Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma | |
| EP3495398A4 (en) | COPOLYMER AS WELL AS SEPARATION MEMBRANE, MEDICAL DEVICE AND BLOOD PURIFIER IN WHICH THIS COPOLYMER IS USED | |
| CL2021000532A1 (es) | Vacunas peptídicas | |
| BR112015023738B8 (pt) | Vacinas de nucleoproteina influenza | |
| WO2015140172A3 (en) | A medicament for use in a method of inducing or extending a cellular cytotoxic immune response | |
| MX2017016346A (es) | Metodos de tratamiento con taselisib. | |
| AR109279A1 (es) | Anticuerpos anti plazomicina y métodos de uso de los mismos | |
| AR100824A1 (es) | Complejo de poliproteínas inmunogénicas de m. hyopneumoniae, gen sintético codificante del complejo de proliproteínas inmunogénicas de m. hyopneumoniae, composición antigénica, proceso de obtención de un complejo de poliproteínas inmunogénicas de m. hyopneumoniae, uso de una composición con base en el complejo de poliproteínas inmunogénicas de m. hyopneumoniae | |
| NZ728041A (en) | Substances and methods for the use in prevention and/or treatment in huntington’s disease | |
| WO2016011432A3 (en) | Identification of immunogenic mhc class ii peptides for immune-based therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |